Sameeksha Pharmaceuticals

Pharmaceutical manufacturing, trading, and export services in healthcare.

About Sameeksha Pharmaceuticals

Sameeksha Pharmaceuticals is a Healthcare company. Pharmaceutical manufacturing, trading, and export services in healthcare. Its Indian entity Sameeksha Pharmaceuticals Private Limited reported revenue of β‚Ή8.61 Cr. Sameeksha Pharmaceuticals offers products and services including Oncology Drugs and Antibiotics. Its focus areas include International Trade, Export, Global Distribution and Pharmaceuticals.

Company details

Sameeksha Pharmaceuticals was founded in 2016 in Pune, Maharashtra, and is noted for its focus on delivering pharmaceutical formulations in areas such as oncology, antibiotics, and injectables. It is backed by over 15 years of industry expertise and operates with a commitment to quality and regulatory compliance. The company is involved in manufacturing, export, and contract services, serving clients across Africa, Latin America, and other regions, while adhering to international standards like WHO-GMP. Investments are made in RD and market expansion to support global health needs.

Key Metrics
  • Indian entity revenue
    ₹8.61 Cr

    FY 2024 · -91% YoY

  • Indian entity net profit
    ₹69.9 Lakh

    FY 2024 · 8% margin

  • Indian entity EBITDA
    ₹73.4 Lakh

    FY 2024 · 9% margin

Products & Services of Sameeksha Pharmaceuticals

Sameeksha Pharmaceuticals offers a comprehensive portfolio of products and services, including Oncology Drugs and Antibiotics.

Oncology Drugs
Pharmaceutical Products

Formulations for cancer care are manufactured and distributed globally.

Antibiotics
Pharmaceutical Products

Antibacterial and antiviral medications are produced for treating infections.

Board of directors of Sameeksha Pharmaceuticals Private Limited (Sameeksha Pharmaceuticals)

Sameeksha Pharmaceuticals Private Limited is the primary company behind Sameeksha Pharmaceuticals. The board of Sameeksha Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Samiksha Samir Gaikwad, appointed in 2016.

DirectorDesignationAppointedTenureEntity
Samiksha Samir Gaikwad
DIN 07494384
Director01 May 201610 yrs 6 moSameeksha Pharmaceuticals Private Limited
Samir Madhukar Gaikwad
DIN 07494688
Director01 May 201610 yrs 6 moSameeksha Pharmaceuticals Private Limited

Financials of Sameeksha Pharmaceuticals

Figures of Sameeksha Pharmaceuticals Private Limited, the primary company behind Sameeksha Pharmaceuticals, for FY 2024. Revenue was ₹8.61 Cr (-91% year on year). Net profit was ₹69.9 Lakh (8% margin). EBITDA was ₹73.4 Lakh (9% margin). Revenue has grown at a compounded annual rate of +547% over three years and +43% over five years.

  • ₹8.61 CrRevenue · FY 2024 · -91% YoY
  • ₹69.9 LakhNet profit · 8% margin
  • ₹73.4 LakhEBITDA · 9% margin
  • ₹1 LakhPaid-up capital
  • +547%Revenue CAGR, 3 years
  • +43%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Sameeksha Pharmaceuticals Private Limited are on its company page.

Premium access

Detailed financial statements for Sameeksha Pharmaceuticals

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Sameeksha Pharmaceuticals

The primary company behind Sameeksha Pharmaceuticals, Sameeksha Pharmaceuticals Private Limited, reported revenue of β‚Ή8.61 Cr for FY 2024, down 91% year on year.

Sameeksha Pharmaceuticals was founded in 2016 in Pune, Maharashtra, and is noted for its focus on delivering pharmaceutical formulations in areas such as oncology, antibiotics, and injectables. It is backed by over 15 years of industry expertise and operates with a commitment to quality and regulatory compliance. The company is involved in manufacturing, export, and contract services, serving clients across Africa, Latin America, and other regions, while adhering to international standards like WHO-GMP. Investments are made in RD and market expansion to support global health needs.

Sameeksha Pharmaceuticals offers Oncology Drugs and Antibiotics.

Sameeksha Pharmaceuticals operates through Sameeksha Pharmaceuticals Private Limited.

The legal entities of Sameeksha Pharmaceuticals currently have 2 directors, including Samiksha Samir Gaikwad, Samir Madhukar Gaikwad.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available